Efficacy of orally and topically administered fluralaner (Bravecto®) for treatment of client-owned dogs with sarcoptic mange under field conditions

被引:0
|
作者
Rafael Chiummo
Ivo Petersen
Claudia Plehn
Eva Zschiesche
Rainer Roepke
Emmanuel Thomas
机构
[1] MSD Animal Health Innovation GmbH,
来源
关键词
Bravecto; dog; field; fluralaner; sarcoptic mange;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 34 条
  • [21] A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA
    Daniela Karadzovska
    Kimberly Chappell
    Shane Coble
    Martin Murphy
    Daniela Cavalleri
    Scott Wiseman
    Jason Drake
    Steve Nanchen
    Parasites & Vectors, 10
  • [22] A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries
    Daniela Cavalleri
    Martin Murphy
    Wolfgang Seewald
    Jason Drake
    Steve Nanchen
    Parasites & Vectors, 10
  • [23] A blinded, randomized and controlled multicenter field study investigating the safety and efficacy of long-term use of enflicoxib in the treatment of naturally occurring osteoarthritis in client-owned dogs
    Homedes, Josep
    Ocak, Marion
    Riedle, Sebastian
    Salichs, Marta
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [24] A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA
    Karadzovska, Daniela
    Chappell, Kimberly
    Coble, Shane
    Murphy, Martin
    Cavalleri, Daniela
    Wiseman, Scott
    Drake, Jason
    Nanchen, Steve
    PARASITES & VECTORS, 2017, 10
  • [25] Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA
    Lisa M. Young
    Scott Wiseman
    Elizabeth Crawley
    Kim Wallace
    Daniel E. Snyder
    Parasites & Vectors, 14
  • [26] Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA
    Young, Lisa M.
    Wiseman, Scott
    Crawley, Elizabeth
    Wallace, Kim
    Snyder, Daniel E.
    PARASITES & VECTORS, 2021, 14 (01)
  • [27] A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries
    Cavalleri, Daniela
    Murphy, Martin
    Seewald, Wolfgang
    Drake, Jason
    Nanchen, Steve
    PARASITES & VECTORS, 2017, 10
  • [28] Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany
    Hampel, Verena
    Knaus, Martin
    Schaefer, Juergen
    Beugnet, Frederic
    Rehbein, Steffen
    PARASITE, 2018, 25
  • [29] Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: Results of a European field study
    Krieger K.
    Heine J.
    Dumont P.
    Hellmann K.
    Parasitology Research, 2005, 97 (Suppl 1) : S81 - S88
  • [30] Efficacy of monthly treatment with oral fluralaner (Bravecto® 1-Month) against Tunga penetrans in dogs in Brazil: a randomized, double-blind, controlled field study
    dos Santos, Katharine Costa
    Guedes, Paula Elisa Brandao
    Albuquerque, George Rego
    de Jesus, Anderson Vieira
    da Paixao Seva, Anaia
    de Oliveira, Joana Thaisa Santos
    de Carvalho Teixeira, Jamille Bispo
    Bitar, Thammy Vieira
    Harvey, Tatiani Vitor
    Ramos, Sofia Nadir Sanches
    Barufi, Francisco Bonomi
    de Almeida Borges, Fernando
    Carlos, Renata Santiago Alberto
    PARASITES & VECTORS, 2024, 17 (01)